Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Current Deferred Revenue: 2010-2024

Historic Current Deferred Revenue for National Research (NRC) over the last 15 years, with FY2024 value amounting to $15.8 million.

  • National Research's Current Deferred Revenue rose 296.51% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year increase of 296.51%. This contributed to the annual value of $15.8 million for FY2024, which is 641.77% up from last year.
  • National Research's Current Deferred Revenue amounted to $15.8 million in FY2024, which was up 641.77% from $14.8 million recorded in FY2023.
  • National Research's 5-year Current Deferred Revenue high stood at $17.2 million for FY2021, and its period low was $14.8 million during FY2023.
  • For the 5-year period, National Research's Current Deferred Revenue averaged around $15.7 million, with its median value being $15.6 million (2020).
  • In the last 5 years, National Research's Current Deferred Revenue skyrocketed by 1044.59% in 2021 and then plummeted by 1170.63% in 2022.
  • Over the past 5 years, National Research's Current Deferred Revenue (Annual) stood at $15.6 million in 2020, then grew by 10.45% to $17.2 million in 2021, then decreased by 11.71% to $15.2 million in 2022, then decreased by 2.4% to $14.8 million in 2023, then rose by 6.42% to $15.8 million in 2024.
  • Its Current Deferred Revenue was $15.8 million in FY2024, compared to $14.8 million in FY2023 and $15.2 million in FY2022.